Emergent BioSolutions
EBS
#7517
Rank
โ‚น41.71 B
Marketcap
โ‚น808.50
Share price
0.96%
Change (1 day)
45.99%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): โ‚น14.36 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are โ‚น0.75 Billion. In 2024 the company made an earning of -โ‚น6.88 Billion, an increase over its 2023 earnings that were of -โ‚น61.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น14.36 B-308.87%
2024 -โ‚น6.88 Billion-88.82%
2023 -โ‚น61.56 Billion242.73%
2022 -โ‚น17.96 Billion-153.8%
2021 โ‚น33.38 B-20.43%
2020 โ‚น41.95 B278.02%
2019 โ‚น11.09 B27.11%
2018 โ‚น8.73 B-27.12%
2017 โ‚น11.98 B17.21%
2016 โ‚น10.22 B0.45%
2015 โ‚น10.17 B73.51%
2014 โ‚น5.86 B41.36%
2013 โ‚น4.14 B35.2%
2012 โ‚น3.06 B0.4%
2011 โ‚น3.05 B-56.46%
2010 โ‚น7.02 B76.73%
2009 โ‚น3.97 B32.94%
2008 โ‚น2.98 B-5.62%
2007 โ‚น3.16 B
2005 โ‚น4.58 B269.89%
2004 โ‚น1.23 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.013 T 6,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.258 T 7,856.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น957.89 B 5,956.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚น1.19 Billion-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น8.63 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น27.5 Billion-273.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น217.28 B 1,273.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel